Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

FDA approves Wilate for hemophilia A

Oct. 9, 2019

Discovery of novel potent fully human FVIII mimetic BiAb, KY-1049

Oct. 9, 2019

BARDA contract supports Platelet BioGenesis' development of donor-independent platelets

Oct. 8, 2019

Phase I study of CSL-200 gene therapy in adults with severe sickle cell disease

Oct. 3, 2019

Neurotransmitter receptor stimulates early blood cell progenitors

Oct. 2, 2019

Japanese approval for Evrenzo for anemia associated with chronic kidney disease in dialysis patients

Sep. 20, 2019

Inflammation stress induces red blood cell formation

Sep. 18, 2019

Edoxaban in atrial fibrillation patients after PCI: Results from ENTRUST-AF PCI

Sep. 17, 2019

Pharvaris announces financing to advance clinical development of HAE oral therapy

Sep. 13, 2019

First safety data presented from phase II trial of revacept

Sep. 5, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...